218 related articles for article (PubMed ID: 30973901)
1. ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.
Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H
PLoS One; 2019; 14(4):e0214867. PubMed ID: 30973901
[TBL] [Abstract][Full Text] [Related]
2. Reverse transcription-polymerase chain reaction and western blotting analysis for detection of p63 isoforms in uterine cervical cancers.
Lin Z; Nan Y; Zhang X; Zhao Y; Kim C; Kim I
Int J Gynecol Cancer; 2006; 16(4):1643-7. PubMed ID: 16884378
[TBL] [Abstract][Full Text] [Related]
3. Expression Profile of MicroRNA-203 and its ΔNp63 Target in Cervical Carcinogenesis: Prospects for Cervical Cancer Screening.
Coimbra EC; DA Conceição Gomes Leitão M; Júnior MR; DE Oliveira TH; DA Costa Silva Neto J; DE Freitas AC
Anticancer Res; 2016 Aug; 36(8):3939-46. PubMed ID: 27466497
[TBL] [Abstract][Full Text] [Related]
4. Overexpression and ratio disruption of ΔNp63 and TAp63 isoform equilibrium in endometrial adenocarcinoma: correlation with obesity, menopause, and grade I/II tumors.
Vakonaki E; Soulitzis N; Sifakis S; Papadogianni D; Koutroulakis D; Spandidos DA
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1271-8. PubMed ID: 22441934
[TBL] [Abstract][Full Text] [Related]
5. Synergetic Effects of Intronic Mature miR-944 and ΔNp63 Isoforms on Tumorigenesis in a Cervical Cancer Cell Line.
Kim J; Park S; Chang Y; Park KH; Lee H
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764455
[No Abstract] [Full Text] [Related]
6. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
[TBL] [Abstract][Full Text] [Related]
7. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B
Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502
[TBL] [Abstract][Full Text] [Related]
8. Expression and regulation of the ΔN and TAp63 isoforms in salivary gland tumorigenesis clinical and experimental findings.
Mitani Y; Li J; Weber RS; Lippman SL; Flores ER; Caulin C; El-Naggar AK
Am J Pathol; 2011 Jul; 179(1):391-9. PubMed ID: 21703418
[TBL] [Abstract][Full Text] [Related]
9. BORIS and CTCF are overexpressed in squamous intraepithelial lesions and cervical cancer.
Velázquez-Hernández N; Reyes-Romero MA; Barragán-Hernández M; Guerrero-Romero F; Rodríguez-Moran M; Aguilar-Durán M; Lazalde Medina B
Genet Mol Res; 2015 Jun; 14(2):6094-100. PubMed ID: 26125810
[TBL] [Abstract][Full Text] [Related]
10. Frequent alteration of p63 expression in human primary bladder carcinomas.
Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG
Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040
[TBL] [Abstract][Full Text] [Related]
11. A global analysis of the complex landscape of isoforms and regulatory networks of p63 in human cells and tissues.
Sethi I; Romano RA; Gluck C; Smalley K; Vojtesek B; Buck MJ; Sinha S
BMC Genomics; 2015 Aug; 16():584. PubMed ID: 26251276
[TBL] [Abstract][Full Text] [Related]
12. Aberrant DNA methylation of DLX4 and SIM1 is a predictive marker for disease progression of uterine cervical low-grade squamous intraepithelial lesion.
Sakane J; Taniyama K; Miyamoto K; Saito A; Kuraoka K; Nishimura T; Sentani K; Oue N; Yasui W
Diagn Cytopathol; 2015 Jun; 43(6):462-70. PubMed ID: 25614457
[TBL] [Abstract][Full Text] [Related]
13. Expression of p63 (TA and deltaN isoforms) in human primary well differentiated buccal carcinomas.
Chen YK; Hsue SS; Lin LM
Int J Oral Maxillofac Surg; 2004 Jul; 33(5):493-7. PubMed ID: 15183414
[TBL] [Abstract][Full Text] [Related]
14. The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63.
Helton ES; Zhu J; Chen X
J Biol Chem; 2006 Feb; 281(5):2533-42. PubMed ID: 16319057
[TBL] [Abstract][Full Text] [Related]
15. Role of the TAp63 Isoform in Recurrent Nasal Polyps.
Terrinoni A; Palombo R; Pitolli C; Caporali S; De Berardinis R; Ciccarone S; Lanzillotta A; Mauramati S; Porta G; Minieri M; Melino G; Bernardini S; Bruno E
Folia Biol (Praha); 2019; 65(4):170-180. PubMed ID: 31903890
[TBL] [Abstract][Full Text] [Related]
16. Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry.
Nekulova M; Holcakova J; Nenutil R; Stratmann R; Bouchalova P; Müller P; Mouková L; Coates PJ; Vojtesek B
Virchows Arch; 2013 Sep; 463(3):415-25. PubMed ID: 23887585
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
[TBL] [Abstract][Full Text] [Related]
18. Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes.
Abbas HA; Bui NHB; Rajapakshe K; Wong J; Gunaratne P; Tsai KY; Coarfa C; Flores ER
Cancer Res; 2018 Jan; 78(2):451-462. PubMed ID: 29180475
[TBL] [Abstract][Full Text] [Related]
19. Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.
Gunaratne PH; Pan Y; Rao AK; Lin C; Hernandez-Herrera A; Liang K; Rait AS; Venkatanarayan A; Benham AL; Rubab F; Kim SS; Rajapakshe K; Chan CK; Mangala LS; Lopez-Berestein G; Sood AK; Rowat AC; Coarfa C; Pirollo KF; Flores ER; Chang EH
Cancer; 2019 Jul; 125(14):2409-2422. PubMed ID: 31012964
[TBL] [Abstract][Full Text] [Related]
20. Aberrantly elevated Bmi1 promotes cervical cancer tumorigenicity and tumor sphere formation via enhanced transcriptional regulation of Sox2 genes.
Xu R; Chen L; Yang WT
Oncol Rep; 2019 Aug; 42(2):688-696. PubMed ID: 31173263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
